Auditory Impairment in Infants at Risk for Bilirubin-Induced Neurologic Dysfunction

Seminars in Perinatology

Volumn 35, Issue 3, 2011, Pages 162-170

  Shapiro, Steven M ^a   Popelka, Gerald R ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Auditory; Auditory dys synchrony; Auditory neuropathy; Bilirubin; Kernicterus

Indexed keywords

BILIRUBIN;

BILIRUBIN BLOOD LEVEL; BRAIN STEM; COCHLEA; COCHLEA PROSTHESIS; DISEASE ASSOCIATION; HEALTH EDUCATION; HEARING AID; HEARING IMPAIRMENT; HEARING LOSS; HUMAN; INFANT; LANGUAGE DEVELOPMENT; MIDDLE EAR; NERVE CELL; NEUROLOGIC DISEASE; NEWBORN SCREENING; NONHUMAN; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SENSORY SYSTEM ELECTROPHYSIOLOGY; SPEECH DEVELOPMENT; VESTIBULOCOCHLEAR NERVE DISEASE;

COCHLEA; COCHLEAR IMPLANTATION; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HEARING DISORDERS; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN;

EID: 79957929688     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2011.02.011     Document Type: Review

References (106)

1. Schmorl C., des Zur K. Ikterus neonatorum, insbesondere der dabei auftretenden gehirnveränderungen. Verh Dtsch Pathol Ges 1904, 6:109-115.
2. Hansen T.W. Pioneers in the scientific study of neonatal jaundice and kernicterus. Pediatrics 2000, 106:E15.
3. Hsia D.Y.Y., Allen F.H., Gellis S.S. Erthoblastosis fetalis: VIII. Studies of serum bilirubin in relation to kernicterus. N Engl J Med 1952, 247:668-671.
4. Bjerre J.V., Ebbesen F. Incidence of kernicterus in newborn infants in Denmark [in Danish]. Ugeskr Laeger 2006, 168:686-691.
5. Shapiro S.M. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005, 25:54-59.
6. Shapiro S.M. Chronic bilirubin encephalopathy: Diagnosis and outcome. Semin Fetal Neonat Med 2010, 15:157-163.
7. Silva R., Mata L.R., Gulbenkian S., et al. Inhibition of glutamate uptake by unconjugated bilirubin in cultured cortical rat astrocytes: Role of concentration and pH. Biochem Biophys Res Commun 1999, 265:67-72.
8. Silva R.F., Rodrigues C.M., Brites D. Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. J Hepatol 2001, 34:402-408.
9. Silva R.F., Mata L.M., Gulbenkian S., et al. Endocytosis in rat cultured astrocytes is inhibited by unconjugated bilirubin. Neurochem Res 2001, 26:793-800.
10. Rodrigues C.M., Sola S., Silva R.F., et al. Aging confers different sensitivity to the neurotoxic properties of unconjugated bilirubin. Pediatr Res 2002, 51:112-118.
11. Falcao A.S., Fernandes A., Brito M.A., et al. Bilirubin-induced inflammatory response, glutamate release, and cell death in rat cortical astrocytes are enhanced in younger cells. Neurobiol Dis 2005, 20:199-206.
12. Falcao A.S., Silva R.F., Fernandes A., et al. Influence of hypoxia and ischemia preconditioning on bilirubin damage to astrocytes. Brain Res 2007, 1149:191-199.
13. Falcao A.S., Silva R.F., Pancadas S., et al. Apoptosis and impairment of neurite network by short exposure of immature rat cortical neurons to unconjugated bilirubin increase with cell differentiation and are additionally enhanced by an inflammatory stimulus. J Neurosci Res 2007, 85:1229-1239.
14. Falcao A.S., Bellarosa C., Fernandes A., et al. Role of multidrug resistance-associated protein 1 expression in the in vitro susceptibility of rat nerve cell to unconjugated bilirubin. Neuroscience 2007, 144:878-888.
15. Grojean S., Koziel V., Vert P., et al. Bilirubin induces apoptosis via activation of NMDA receptors in developing rat brain neurons. Exp Neurol 2000, 166:334-341.
16. Grojean S., Lievre V., Koziel V., et al. Bilirubin exerts additional toxic effects in hypoxic cultured neurons from the developing rat brain by the recruitment of glutamate neurotoxicity. Pediatr Res 2001, 49:507-513.
17. Hanko E., Hansen T.W., Almaas R., et al. Bilirubin induces apoptosis and necrosis in human NT2-N neurons. Pediatr Res 2005, 57:179-184.
18. Hanko E., Hansen T.W., Almaas R., et al. Synergistic protection of a general caspase inhibitor and MK-801 in bilirubin-induced cell death in human NT2-N neurons. Pediatr Res 2006, 59:72-77.
19. Shapiro S.M., Churn S.B., Pal S., et al. Bilirubin alters intracellular calcium homeostasis. Pediatr Res 1998, 42:195A.
20. Spencer R.F., Shaia W.T., Gleason A.T., et al. Changes in calcium-binding protein expression in the auditory brainstem nuclei of the jaundiced Gunn rat. Hear Res 2002, 171:129-141.
21. Greengard P. Neuronal phosphoproteins. Mediators of signal transduction. Mol Neurobiol 1987, 1:51-119.
22. Schulman H. Advances in Second Messenger and Phosphoprotein Research 1989, 39-112. Raven Press, New York. P. Greengard, G.A. Robinson (Eds.).
23. Malinow R., Schulman H., Tsien R.W. Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP. Science 1989, 245:862-866.
24. Churn S.B., Taft W.C., DeLorenzo R.J. Effect of ischemia on multifunction calcium/calmodulin-dependent protein kinase II in the gerbil. Stroke 1990, III(Suppl):112-116.
25. Perlin J.B., Churn S.B., Lothman E.W., et al. Loss of type II calcium/calmodulin-dependent kinase activity correlates with stages of development of electrographic seizures in status epilepticus in rat. Epilepsy Res 1992, 11:111-118.
26. Churn S.B., Kochan L.D., DeLorenzo R.J. Chronic inhibition of Ca(2+)/calmodulin kinase II activity in the pilocarpine model of epilepsy. Brain Res 2000, 875:66-77.
27. Kochan L.D., Churn S.B., Omojokun O., et al. Status epilepticus results in an N-methyl-d-aspartate receptor-dependent inhibition of Ca2+/calmodulin-dependent kinase II activity in the rat. Neuroscience 2000, 95:735-743.
28. Churn S.B. Multifunctional calcium and calmodulin-dependent kinase II in neuronal function and disease. Adv Neuroimmunol 1995, 5:241-259.
29. Churn S.B., Yaghmai A., Povlishock J., et al. Global forebrain ischemia results in decreased immunoreactivity of calcium/calmodulin-dependent protein kinase II. J Cereb Blood Flow Metab 1992, 12:784-893.
30. Churn S.B., Taft W.C., Billingsley M.S., et al. Global forebrain ischemia induces a posttranslational modification of multifunctional calcium- and calmodulin-dependent kinase II. J Neurochem 1992, 59:1221-1232.
31. Waxham M.N., Grotta J.C., Silva A.J., et al. Ischemia-induced neuronal damage: A role for calcium/calmodulin-dependent protein kinase II. J Cereb Blood Flow Metab 1996, 16:1-6.
32. Singleton M.W., Holbert W.H., Lee A.T., et al. Modulation of CaM kinase II activity is coincident with induction of status epilepticus in the rat pilocarpine model. Epilepsia 2005, 46:1389-1400.
33. Singleton M.W., Holbert W.H., Ryan M.L., et al. Age dependence of pilocarpine-induced status epilepticus and inhibition of CaM kinase II activity in the rat. Brain Res Dev Brain Res 2005, 156:67-77.
34. Folkerts M.M., Parks E.A., Dedman J.R., et al. Phosphorylation of calcium calmodulin-dependent protein kinase II following lateral fluid percussion brain injury in rats. J Neurotrauma 2007, 24:638-650.
35. Gardoni F., Picconi B., Ghiglieri V., et al. A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia. J Neurosci 2006, 26:2914-2922.
36. Dublin W. Neurologic lesions of erythroblastosis fetalis in relation to nuclear deafness. Am J Clin Pathol 1951, 21:935-939.
37. Dublin W. Fundamentals of Sensorineural Auditory Pathology 1976, Charles C. Thomas Publisher, Springfield, IL.
38. Haymaker W., Margles C., Pentschew A. Kernicterus and Its Importance in Cerebral Palsy 1961, 21-229. Charles C. Thomas Publisher, Springfield, IL. C.A. Swinyard (Ed.).
39. Ahdab-Barmada M., Moossy J. The neuropathology of kernicterus in the premature neonate: Diagnostic problems. J Neuropathol Exp Neurol 1984, 43:45-56.
40. Gerrard J. Nuclear jaundice and deafness. J Laryngol Otol 1952, 66:39-46.
41. Kelemen G. Erythroblastosis fetalis. Pathologic report on the hearing organs of a newborn infant. AMA Arch Otolaryngol 1956, 63:392-398.
42. Shaia W.T., Shapiro S.M., Spencer R.F. The jaundiced Gunn rat model of auditory neuropathy/dyssynchrony. Laryngoscope 2005, 115:2167-2173.
43. Katar S., Akay H.O., Taskesen M., et al. Clinical and Cranial magnetic resonance imaging (MRI) Findings of 21 patients with serious hyperbilirubinemia. J Child Neurol 2008, 23:415-417.
44. Gkoltsiou K., Tzoufi M., Counsell S., et al. Serial brain MRI and ultrasound findings: Relation to gestational age, bilirubin level, neonatal neurologic status and neurodevelopmental outcome in infants at risk of kernicterus. Early Hum Dev 2008, 84:829-838.
45. Shah Z., Chawla A., Patkar D., et al. MRI in kernicterus. Australas Radiol 2003, 47:55-57.
46. Govaert P., Lequin M., Swarte R., et al. Changes in globus pallidus with (pre)term kernicterus. Pediatrics 2003, 112:1256-1263.
47. Johnston M.V., Hoon A.H. Possible mechanisms in infants for selective basal ganglia damage from asphyxia, kernicterus, or mitochondrial encephalopathies. J Child Neurol 2000, 15:588-591.
48. Chisin R., Perlman M., Sohmer H. Cochlear and brain stem responses in hearing loss following neonatal hyperbilirubinemia. Ann Otol 1979, 88:352-357.
49. Berlin C.I., Hood L.J., Morlet T., et al. Multi-site diagnosis and management of 260 patients with auditory neuropathy/Dys-synchrony (auditory neuropathy spectrum disorder). Int J Audiol 2010, 49:30-43.
50. Powers K.M., Miller S., Shapiro S.M. Exposure to excessive hyperbilirubinemia earlier in neurodevelopment is associated with auditory-predominant kernicterus subtype. Ann Neurol 2008, 64(Suppl. 12):S105.
51. Conlee J.W., Shapiro S.M. Development of cerebellar hypoplasia in jaundiced Gunn rats treated with sulfadimethoxine: A quantitative light microscopic analysis. Acta Neuropathol 1997, 93:450-460.
52. Crabtree N., Gerrard J. Perceptive deafness associated with severe neonatal jaundice; a report of 16 cases. J Laryngol Otol 1950, 64:482-506.
53. Flottorp G., Morley D.E., Skatvedt M. The localization of hearing impairment in athetoids. Acta Otolaryngol 1957, 48:404-414.
54. Hardy W.G. Kernicterus and Its Importance in Cerebral Palsy 1961, 21-228. Charles, Thomas C. C.A. Swinyard (Ed.).
55. Keaster J., Hyman C.B., Harris I., et al. Hearing problems subsequent to neonatal hemolytic disease or hyperbilirubinemia. Am J Dis Child 1969, 117:406-410.
56. Matkin N.D., Carhart R. Auditory profiles associated with Rh incompatibility. Arch Otolaryngol 1966, 84:502-513.
57. Perlstein M.A. The late clinical syndrome of posticteric encephalopathy. Pediatr Clin North Am 1960, 7:665-687.
58. Rosen J. Rh child: deaf or aphasic? 4. Variations in the auditory disorders of the Rh child. J Speech Hear Disord 1956, 21:418-422.
59. Ruben R., Lieberman A., Bordley J. Some observations on cochlear potentials and nerve action potentials in children. Laryngoscope 1962, 72:545-553.
60. Byers R.K., Paine R.S., Crothers B. Extrapyramidal cerebral palsy with hearing loss following erythroblastosis. Pediatrics 1955, 15:248-254.
61. Shapiro S.M. Binaural effects in brainstem auditory evoked potentials of jaundiced Gunn rats. Hear Res 1991, 53:41-48.
62. Huang C.-M., Buchwald J.S. Interpretation of the vertex short-latency acoustic response: A study of single neurons in the brain stem. Brain Res 1977, 137:291-303.
63. Jewett D.L., Romano M.N. Neonatal development of auditory system potentials averaged from the scalp of rat and cat. Brain Res 1972, 36:101-115.
64. Melcher J.R., Guinan J.J., Knudson I.M., et al. Generators of the brainstem auditory evoked potential in cat. II. Correlating lesion sites with waveform changes. Hear Res 1996, 93:28-51.
65. Starr A., Hamilton A.E. Correlation between confirmed sites of neurological lesions and abnormalities of far-field auditory brainstem responses. Electroenceph Clin Neurophysiol 1976, 41:595-608.
66. Hecox K.E., Cone B., Blaw M.E. Brainstem auditory evoked response in the diagnosis of pediatric neurologic diseases. Neurology 1981, 31:832-839.
67. Starr A. Sensory evoked potentials in clinical disorders of the nervous system. Annu Rev Neurosci 1978, 1:103-127.
68. Greenberg R.P., Ducker T.B. Evoked potentials in the clinical neurosciences. J Neurosurg 1982, 56:1-18.
69. Kaga K., Kitazumi E., Kodama K. Auditory brain stem responses of kernicterus infants. Int J Pediatr Otorhinolaryngol 1979, 1:255-294.
70. Lenhardt M.L., McArtor R., Bryant B. Effects of neonatal hyperbilirubinemia on the brainstem electric response. J Pediatr 1984, 104:281-284.
71. Nakamura H., Takada S., Shimabuku R., et al. Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 1985, 75:703-708.
72. Perlman M., Fainmesser P., Sohmer H., et al. Auditory nerve-brainstem evoked responses in hyperbilirubinemic neonates. Pediatrics 1983, 72:658-664.
73. Kotagal S., Rudd D., Rosenberg C., et al. Brain-stem auditory evoked potentials in neonatal hyperbilirubinemia. Neurologist 1981, 31:48.
74. Nwaesei C.G., Van Aerde J., Boyden M., et al. Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion. Pediatrics 1984, 74:800-803.
75. Wennberg R.P., Ahlfors C.E., Bickers R., et al. Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: Improvement with exchange transfusion. J Pediatr 1982, 100:624-626.
76. Funato M., Tamai H., Shimada S., et al. Unbound bilirubin, and auditory brainstem responses. Pediatrics 1994, 93:50-53.
77. Jirka J.H., Duckrow R.B., Kendig J.W., et al. Effect of bilirubin on brainstem auditory evoked potentials in the asphyxiated rat. Pediatr Res 1985, 19:556-560.
78. Ahlfors C.E., Bennett S.H., Shoemaker C.T., et al. Changes in the auditory brainstem response associated with intravenous infusion of unconjugated bilirubin into infant rhesus monkeys. Pediatr Res 1986, 20:511-515.
79. Shapiro S.M., Hecox K.E. Brain stem auditory evoked potentials in jaundiced Gunn rats. Ann Otol Rhinol Laryngol 1989, 98:308-317.
80. Shapiro S.M., Hecox K.E. Development of brainstem auditory evoked potentials in heterozygous and homozygous jaundiced Gunn rats. Brain Res 1988, 469:147-157.
81. Uziel A., Marot M., Pujol R. The Gunn rat: An experimental model for central deafness. Acta Otolaryngol 1983, 95:651-656.
82. Jew J.Y., Williams T.H. Ultrastructural aspects of bilirubin encephalopathy in cochlear nuclei of the Gunn rat. J Anat 1977, 124:599-614.
83. Jew J.Y., Sandquist D. CNS changes in hyperbilirubinemia. Functional implications. Arch Neurol 1979, 36:149-154.
84. Conlee J.W., Shapiro S.M. Morphological changes in the cochlear nucleus and nucleus of the trapezoid body in Gunn rat pups. Hear Res 1991, 57:23-30.
85. Shapiro S.M., Conlee J.W. Brainstem auditory evoked potentials correlate with morphological changes in Gunn rat pups. Hear Res 1991, 57:16-22.
86. Diamond I., Schmid R. Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system. J Clin Invest 1966, 45:678-689.
87. Shapiro S.M. Acute brainstem auditory evoked potential abnormalities in jaundiced Gunn rats given sulfonamide. Pediatr Res 1988, 23:306-310.
88. Shapiro S.M. Reversible brainstem auditory evoked potential abnormalities in jaundiced Gunn rats given sulfonamide. Pediatr Res 1993, 34:629-633.
89. Dobie R.A. Binaural interaction in brainstem-evoked responses. Arch Otolaryngol 1979, 105:391-398.
90. Shaia W.T., Shapiro S.M., Heller A.J., et al. Immunohistochemical localization of calcium-binding proteins in the brainstem vestibular nuclei of the jaundiced Gunn rat. Hear Res 2002, 173:82-90.
91. Peterson A., Shallop J., Driscoll C., et al. Outcomes of cochlear implantation in children with auditory neuropathy. J Am Acad Audiol 2003, 14:188-201.
92. Buchman C.A., Roush P.A., Teagle H.F., et al. Auditory neuropathy characteristics in children with cochlear nerve deficiency. Ear Hear 2006, 27:399-408.
93. Gibson W.P.R., Sanli H. Auditory neuropathy: An update. Ear Hear 2007, 28:102S-106S.
94. Attias J., Raveh E. Transient deafness in young candidates for cochlear implants. Audiol Neuro Otol 2007, 12:325-333.
95. Raveh E., Buller N., Badrana O., et al. Auditory neuropathy: Clinical characteristics and therapeutic approach. Am J Otolaryngol 2007, 28:302-308.
96. Jeong S.-W., Kim L.-S., Kim B.-Y., et al. Cochlear implantation in children with auditory neuropathy: Outcomes and rationale. Acta Otolaryngol Suppl 2007, 36-43.
97. Walton J., Gibson W.P.R., Sanli H., et al. Predicting cochlear implant outcomes in children with auditory neuropathy. Otol Neurotol 2008, 29:302-309.
98. Rance G., Barker E.J. Speech perception in children with auditory neuropathy/dyssynchrony managed with either hearing AIDS or cochlear implants. Otol Neurotol 2008, 29:179-182.
99. Rance G., Barker E.J. Speech and language outcomes in children with auditory neuropathy/Dys-synchrony managed with either cochlear implants or hearing aids. Int J Audiol 2009, 48:313-320.
100. Berlin C.I., Hood L.J., Morlet T., et al. Multi-site diagnosis and management of 260 patients with auditory neuropathy/Dys-synchrony (auditory neuropathy spectrum disorder). Int J Audiol 2010, 49:30-43.
101. Teagle H.F.B., Roush P.A., Woodard J.S., et al. Cochlear implantation in children with auditory neuropathy spectrum disorder. Ear Hear 2010, 31:325-335.
102. Berlin C.I., Hood L., Morlet T., et al. Auditory neuropathy/Dys-synchrony: Diagnosis and management. Ment Retard Dev Disabil Res Rev 2003, 9:225-231.
103. Wilson Reading System Education Commission of the States, Accessed March 9, 2011. http://www.ecs.org/clearinghouse/19/01/1901.htm.
104. Wilson B.A. Wilson Reading System 1996, Wilson Language Training, Oxford, MA. 3rd ed.
105. Geiger A.S., Rice A.C., Shapiro S.M. Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats. J Neonatol 2007, 92:219-226.
106. Lin S., Wei X., Bales K.R., et al. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. Eur J Neurosci 2005, 22:21-27.